Thyroid cancer is the most common endocrine malignancy. With a rapidly rising incidence in
recent years, novel efficient management strategies are increasingly needed for this cancer …

Recent molecular studies have described a number of abnormalities associated with the
progression and dedifferentiation of thyroid carcinoma. These distinct molecular events are …

Thyroid cancer is a common endocrine malignancy. There has been exciting progress in
understanding its molecular pathogenesis in recent years, as best exemplified by the …

Differentiated thyroid cancer (DTC) is the most common endocrinological malignancy. There
are several histological variants such as papillary and follicular thyroid carcinoma. Many …

Whole genome sequencing approaches have provided unprecedented insights into the
genetic lesions responsible for the onset, progression and dedifferentiation of various types …

Thyroid cancer is the most common malignancy of the endocrine system, and its incidence
has been steadily increasing. Advances in sequencing have allowed analysis of the entire …

Thyroid cancer (TC) is the most common endocrine malignancy with steadily increasing
incidence over the past few decades. Although standard strategies for the management of …

Thyroid cancer is increasing in incidence. Although often indolent and highly curable
neoplasms, they may recur, metastasize, or become resistant to radio-iodine therapy …

Background: Very little was known about the molecular pathogenesis of thyroid cancer until
the late 1980s. As part of the Centennial celebration of the American Thyroid Association …

Thyroid cancer is the most common endocrine cancer. The discovery of new biomarkers for
thyroid cancer has significantly improved the understanding of the molecular pathogenesis …